| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLMT | Common Stock, par value $0.01 per share | Sale | -$1.62M | -75K | -5.82% | $21.65 | 1.21M | Dec 3, 2024 | Direct | F1 |
| transaction | CLMT | Common Stock, par value $0.01 per share | Options Exercise | $0 | +8.92K | +0.74% | $0.00 | 1.22M | Dec 4, 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLMT | Restricted Stock Unit | Options Exercise | $0 | -8.92K | -100% | $0.00 | 0 | Dec 4, 2024 | Common Stock, par value $0.01 per share | 8.92K | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | On July 10, 2024, in connection with the corporate reorganization of Calumet Specialty Products Partners, L.P. (the "Partnership"), pursuant to which the Partnership converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Partnership, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). In connection with the GP Merger, the reporting person was issued 825,000 shares of Calumet, Inc. common stock, par value $0.01 per share ("Common Stock"), and 300,000 warrants to purchase Common Stock. The reporting person sold the 75,000 shares of Common Stock reported herein to offset a portion of her tax obligations that were incurred as a result of the Conversion transaction. |
| F2 | Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. |
| F3 | 100% of the Restricted Stock Units vested on November 3, 2024. |